Unicycive Therapeutics (UNCY) Leases (2021 - 2026)
Unicycive Therapeutics posted quarterly Leases of $813000.0 for Q1 2026, up 56.95% year-on-year from $518000.0 in Q1 2025, and up 652.78% on a QoQ basis from $108000.0 in Q4 2025.
Unicycive Therapeutics (UNCY) has 6 years of Leases data on file, last reported at $813000.0 in Q1 2026.
- For the quarter ending Q1 2026, Leases rose 56.95% year-over-year to $813000.0; the trailing twelve-month figure through Mar 2026 stood at $813000.0 (up 56.95% YoY), and the FY2025 full-year result was $108000.0, down 83.26% from the prior year.
- Leases for Q1 2026 stood at $813000.0, up from $108000.0 in the prior quarter.
- Across five years, Leases topped out at $997000.0 in Q1 2023 and bottomed at $108000.0 in Q4 2025.
- The 5-year median for Leases is $604000.0 (2024), against an average of $538411.8.
- The widest annual swing landed in 2023, when Leases jumped 403.95%; it then tumbled 83.26% in 2025.
- A 5-year view of Leases shows it stood at $152000.0 in 2022, then surged by 403.95% to $766000.0 in 2023, then fell by 15.8% to $645000.0 in 2024, then sank by 83.26% to $108000.0 in 2025, then soared by 652.78% to $813000.0 in 2026.
- The last three Leases figures came in at $813000.0 (Q1 2026), $108000.0 (Q4 2025), and $249000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | 813,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 813,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | 386,000.00 |
| Mar 31, 2025 | 518,000.00 |
| Dec 31, 2024 | 645,000.00 |
| Sep 30, 2024 | 772,000.00 |
| Jun 30, 2024 | 604,000.00 |
| Mar 31, 2024 | 686,000.00 |
| Dec 31, 2023 | 766,000.00 |
| Sep 30, 2023 | 845,000.00 |
| Jun 30, 2023 | 923,000.00 |
| Mar 31, 2023 | 997,000.00 |
| Dec 31, 2022 | 152,000.00 |
| Sep 30, 2022 | 191,000.00 |
| Jun 30, 2022 | 230,000.00 |
| Mar 31, 2022 | 268,000.00 |
| Dec 31, 2021 | 305,000.00 |